BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 23026597)

  • 1. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
    Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
    Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
    Torregrosa JV; Bergua C; Martinez de Osaba MJ; Oppenheimer F; Campistol JM
    Transplant Proc; 2009; 41(6):2396-8. PubMed ID: 19715931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
    Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
    Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS
    Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet.
    Guerra R; Auyanet I; Fernández EJ; Pérez MÁ; Bosch E; Ramírez A; Suria S; Checa MD
    J Nephrol; 2011; 24(1):78-82. PubMed ID: 20437396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism.
    López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D
    Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism.
    Bergua C; Torregrosa JV; Cofán F; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2254-5. PubMed ID: 17889155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal of cinacalcet at the time of renal transplantation is not a risk factor for allograft calcifications in the early posttransplantation period.
    Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Soler M; Campistol JM
    Transplant Proc; 2012 Oct; 44(8):2379-80. PubMed ID: 23026598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose.
    Kamar N; Gennero I; Spataru L; Esposito L; Guitard J; Lavayssière L; Cointault O; Gandia P; Durand D; Rostaing L
    Nephrol Dial Transplant; 2008 Nov; 23(11):3720-6. PubMed ID: 18558623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study.
    Torregrosa JV; Morales E; Díaz JM; Crespo J; Bravo J; Gómez G; Gentil MÁ; Rodríguez Benot A; García MR; Jiménez VL; Gutiérrez Dalmau A; Jimeno L; Sáez MJ; Romero R; Gómez Alamillo C;
    Nephrology (Carlton); 2014 Feb; 19(2):84-93. PubMed ID: 24428216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure.
    Carrasco FR; Pérez-Flores I; Calvo N; Ridao N; Sánchez A; Barrientos
    Transplant Proc; 2009; 41(6):2385-7. PubMed ID: 19715927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation.
    Gómez Marqués G; Obrador Mulet A; Vilar Gimeno A; Pascual Felip MJ; Alarcón Zurita A; Molina Guasch M; Uriol Rivera M; Munar Vila MA; Losada González P
    Transplant Proc; 2009; 41(6):2139-43. PubMed ID: 19715856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Persistent Hypercalcemia and Hyperparathyroidism With Cinacalcet After Successful Kidney Transplantation.
    Ważna-Jabłońska E; Gałązka Z; Durlik M
    Transplant Proc; 2016 Jun; 48(5):1623-5. PubMed ID: 27496458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in hypercalcemia with cinacalcet after kidney transplantation.
    Srinivas TR; Schold JD; Womer KL; Kaplan B; Howard RJ; Bucci CM; Meier-Kriesche HU
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):323-6. PubMed ID: 17699223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet.
    Wilkie M; Pontoriero G; Macário F; Yaqoob M; Bouman K; Braun J; von Albertini B; Brink H; Maduell F; Graf H; Frazão JM; Bos WJ; Torregrosa V; Saha H; Reichel H; Zani VJ; Carter D; Messa P
    Nephron Clin Pract; 2009; 112(1):c41-50. PubMed ID: 19365139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients.
    Serra AL; Savoca R; Huber AR; Hepp U; Delsignore A; Hersberger M; Wüthrich RP
    Nephrol Dial Transplant; 2007 Feb; 22(2):577-83. PubMed ID: 17005527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
    Lucchi L; Carboni C; Stipo L; Malaguti V; Ferrari F; Graziani R; Arletti S; Graziosi C
    Artif Organs; 2011 Dec; 35(12):1186-93. PubMed ID: 21848793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
    Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
    Nephrol Dial Transplant; 2005 Jul; 20(7):1311-4. PubMed ID: 15941846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
    Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
    N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.